Brief: Rallybio Corp Phase 2 Study For Rlyb212 Expected To Initiate In 2H 2024
04/01/2024 13:55
Jan 4 (Reuters) - Rallybio Corp RLYB.O :
* PHASE 2 STUDY FOR RLYB212 EXPECTED TO INITIATE IN 2H 2024
* CASH RUNWAY EXTENDED INTO 3Q 2025
* EXPECT TO HAVE ADDITIONAL UPDATES TO OUR PLANS AND CASH
RUNWAY
BEFORE END OF Q1
Source text for Eikon: ID:nBw1732C3a
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx